A modified LI-RADS: targetoid tumors with enhancing capsule can be diagnosed as HCC instead of LR-M lesions. Min JH, Kim JM, Kim YK, Kim H, et al. Eur Radiol 2022;32:912-922.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Min JH, Kim JM, Kim YK, Kim H, et al. A modified LI-RADS: targetoid tumors with enhancing capsule can be diagnosed as HCC instead of LR-M lesions. Eur Radiol 2022;32:912-922.
PMID: 34345947